Fig 1: Relative glutamate transporters mRNA expression in NAc brain regions after treatments (data expressed as mean ± SEM). (A) glt-1; (B) xct; (C) nf?B (*p < .05, **p < .01, ***p < .001; n = 5 for each group).
Fig 2: Glutamate transporters level in NAc brain regions after treatments (data expressed as mean ± SEM). (A) GLT-1; (B) xCT; (C) NF?B (*p < .05, **p < .01, ***p < .001; n = 5 for each group).
Fig 3: Relative glutamate transporters mRNA expression in PFC brain regions after treatments (data expressed as mean ± SEM). (A) glt-1; (B) xct; (C) nf?B (*p < .05, **p < .01, ***p < .001; n = 5 for each group).
Fig 4: Glutamate transporters level in PFC brain regions after treatments (data expressed as mean ± SEM). (A) GLT-1; (B) xCT; (C) NF?B (*p < .05, **p < .01, ***p < .001; n = 5 for each group).
Supplier Page from Abcam for Anti-EAAT2 antibody [EPR19794]